Search research articles
Contact Us
Filters
Showing results (51-60 of 455) with videos related to
Page
of 46
Sort By:
International Journal of Molecular Sciences
|
June 9, 2017
Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients
Heiko Schulz, Elisa Schmoeckel, Christina Kuhn, et al.
International Journal of Molecular Sciences
|
January 25, 2018
Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
Heiko Schulz, Christina Kuhn, Simone Hofmann, et al.
Oncology Reports
|
November 24, 2016
Induction of DNA damage and apoptosis in human leukemia cells by efavirenz
Ansgar Brüning, Julia Jückstock, Bernd Kost, et al.
Journal of Visualized Experiments : Jove
|
March 11, 2024
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Fabian Trillsch, Juliane Reichenbach, Bastian Czogalla, et al.
Clinical Case Reports
|
May 3, 2021
Persistent increase of β-hCG level after salpingectomy in tubal pregnancy: Good or bad news?
Pedro Cristiano Pinto Ribeiro, Niklas Amann, Irene Alba Alejandre, et al.
Geburtshilfe Und Frauenheilkunde
|
October 9, 2023
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2-IIB1 Cervical Cancer
Tanja Fehm, Matthias W Beckmann, Sven Mahner, et al.
Frontiers in Immunology
|
July 15, 2022
Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage
Zhi Ma, Huixia Yang, Mirjana Kessler, et al.
Molecular and Clinical Oncology
|
December 2, 2015
Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function
Charlotte VON Bülow, Leticia Oliveira-Ferrer, Thomas Löning, et al.
Journal of Neurology
|
December 24, 2017
No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas
Fabian Trillsch, Peter Eichhorn, Leticia Oliveira-Ferrer, et al.
Archives of Gynecology and Obstetrics
|
June 5, 2017
Promotor analysis of ESR1 in endometrial cancer cell lines, endometrial and endometriotic tissue
Vanessa Todorow, Martina Rahmeh, Simone Hofmann, et al.
Page
of 46
Search research articles
Search
Showing results (51-60 of 455) with videos related to
Sort By:
Page
of 46
International Journal of Molecular Sciences
|
June 9, 2017
Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients
Heiko Schulz, Elisa Schmoeckel, Christina Kuhn, et al.
International Journal of Molecular Sciences
|
January 25, 2018
Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
Heiko Schulz, Christina Kuhn, Simone Hofmann, et al.
Oncology Reports
|
November 24, 2016
Induction of DNA damage and apoptosis in human leukemia cells by efavirenz
Ansgar Brüning, Julia Jückstock, Bernd Kost, et al.
Journal of Visualized Experiments : Jove
|
March 11, 2024
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Fabian Trillsch, Juliane Reichenbach, Bastian Czogalla, et al.
Clinical Case Reports
|
May 3, 2021
Persistent increase of β-hCG level after salpingectomy in tubal pregnancy: Good or bad news?
Pedro Cristiano Pinto Ribeiro, Niklas Amann, Irene Alba Alejandre, et al.
Geburtshilfe Und Frauenheilkunde
|
October 9, 2023
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2-IIB1 Cervical Cancer
Tanja Fehm, Matthias W Beckmann, Sven Mahner, et al.
Frontiers in Immunology
|
July 15, 2022
Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage
Zhi Ma, Huixia Yang, Mirjana Kessler, et al.
Molecular and Clinical Oncology
|
December 2, 2015
Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function
Charlotte VON Bülow, Leticia Oliveira-Ferrer, Thomas Löning, et al.
Journal of Neurology
|
December 24, 2017
No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas
Fabian Trillsch, Peter Eichhorn, Leticia Oliveira-Ferrer, et al.
Archives of Gynecology and Obstetrics
|
June 5, 2017
Promotor analysis of ESR1 in endometrial cancer cell lines, endometrial and endometriotic tissue
Vanessa Todorow, Martina Rahmeh, Simone Hofmann, et al.
Page
of 46